← all works
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Neurology
- Topic
- Dementia and Cognitive Impairment Research
- Field
- Medicine
- Canadian institutions
- McGill UniversityMontreal Neurological Institute and Hospital
- Funders
- European Research CouncilFonds de Recherche du Québec - SantéMontreal Neurological Institute and HospitalUniversity Hospital FoundationWallenberg Centre for Molecular and Translational MedicineVetenskapsrådetHjärnfondenGE HealthcareKnut och Alice Wallenbergs StiftelseLunds UniversitetCanada Foundation for InnovationAlzheimer SocietyConsortium canadien en neurodégénérescence associée au vieillissementAlzheimer's Drug Discovery FoundationCanadian Institutes of Health ResearchAlzheimerfondenWeston Brain InstituteSahlgrenska UniversitetssjukhusetRocheMarcus och Amalia Wallenbergs minnesfondParkinson Research FoundationAssociation for Frontotemporal Degeneration
- Keywords
- MedicineBiomarkerCohortDementiaProspective cohort studyInternal medicineOncologyDiseaseCohort studyCognitive declineFrontotemporal dementiaAlzheimer's disease
- Has abstract in OpenAlex
- no